Document is current

Article History

Received: 17 November 2023

Accepted: 4 March 2024

First Online: 2 April 2024

Declarations

:

: Ethics approval to conduct the survey was sought from and granted by the Beacon Hospital Independent Ethics Committee of Beacon Hospital, Petaling Jaya, Selangor, Malaysia (reference BH/BHIEC/AP-00017).

: The invitation to participate in the survey and the first question of the survey relating to consent are included in Appendix .

: Please note that our response to the consent to participate question above also addresses consent for anonymous survey responses to be included in a subsequent publication.

: Dato’ Dr. Joon Kiong Lee has received honoraria from Amgen, Mylan and Zuellig Pharma for speaking at symposia, as member of advisory board and educational programs and workshops. Adjunct Associate Professor Paul James Mitchell (PJM) has undertaken consultancy for governments, national and international osteoporosis societies, healthcare professional organisations (including APFFA) and private sector companies relating to systematic approaches to fragility fracture care and prevention since 2005. Adjunct Assistant Professor Seng Bin Ang has no disclosures relating to this work. Professor Leilani Basa Mercado-Asis has no disclosures relating to this work. Professor Reynaldo Rey-Matias has no disclosures relating to this work. Professor Jianin Li has no disclosures relating to this work. Professor Leon Flicker has no relevant disclosures. Dr. Edward Leung has no disclosures relating to this work. Professor David Choon has no disclosures relating to this work. Dr. Sankara Kumar Chandrasekaran has no disclosures relating to this work. Professor Jacqueline Clare Therese Close has no disclosures relating to this work. Dr. Hannah Seymour has no disclosures relating to this work. Professor Cyrus Cooper has received consulting fees and honoraria from Amgen, Danone, Eli Lilly, GSK, Medtronic, Merck, Nestle, Novartis, Pfizer, Roche, Servier, Shire, Takeda and UCB. Dr. Philippe Halbout is the Chief Executive Officer of the International Osteoporosis Foundation and has no disclosures relating to this work. Professor Robert Daniel Blank reports the following disclosures: consulting: Guidepoint; advisory board: Amgen; stock ownership: Abbott Labs, Abbvie, Amgen, Doctorpedia, Glaxo, JangoBio, Johnson & Johnson, Procter & Gamble and ROMTech; editorial stipends: Elsevier, Endocrine Society; and royalties: Wolters Kluwer. Dr. Yanling Zhao has no disclosures relating to this work. Professor Rajesh Malhotra has no disclosures relating to this work. Professor Aasis Unnanuntana reports no conflict of interest. Dr. Yew Lok Woo has no disclosures relating to this work. Professor Zairin Noor has no disclosures relating to this work. Professor Rong-Sen Yang reports honoraria from Amgen for speech at symposia. Associate Professor Irewin Tabu has no disclosures relating to this work. Professor Syed Shahidul Islam has no disclosures relating to this work. Professor Muhammad Amin Chinoy has no disclosures relating to this work. Dr. Sonali Pande has no disclosures relating to this work. Professor Buland Thapa has no disclosures relating to this work. Clinical Associate Professor Ronald Man Yeung Wong reports no conflict of interest for this article. Adjunct Professor Ketan Pande has no disclosures to declare. Professor Ding-Chen (Derrick) Chan reports personal fees (consulting fees) from Amgen, Lotus, Eli-Lilly and Harvester Trading Co, Ltd.